Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer Surgery

Christine Miaskowski, Marylin Dodd, Steven M. Paul, Claudia West, Deborah Hamolsky, Gary Abrams, Bruce A. Cooper, Charles Elboim, John Neuhaus, Brian L. Schmidt, Betty Smoot, Bradley E. Aouizerat

Research output: Contribution to journalArticle

Abstract

The purposes of this study were to evaluate for differences in phenotypic and genotypic characteristics in women who did and did not develop lymphedema (LE) following breast cancer treatment. Breast cancer patients completed a number of self-report questionnaires. LE was evaluated using bioimpedance spectroscopy. Genotyping was done using a custom genotyping array. No differences were found between patients with (n = 155) and without LE (n = 387) for the majority of the demographic and clinical characteristics. Patients with LE had a significantly higher body mass index, more advanced disease and a higher number of lymph nodes removed. Genetic associations were identified for four genes (i.e., lymphocyte cytosolic protein 2 (rs315721), neuropilin-2 (rs849530), protein tyrosine kinase (rs158689), vascular cell adhesion molecule 1 (rs3176861)) and three haplotypes (i.e., Forkhead box protein C2 (haplotype A03), neuropilin-2 (haplotype F03), vascular endothelial growth factor-C (haplotype B03)) involved in lymphangiogensis and angiogenesis. These genetic associations suggest a role for a number of lymphatic and angiogenic genes in the development of LE following breast cancer treatment.

Original languageEnglish (US)
Article numbere60164
JournalPLoS One
Volume8
Issue number4
DOIs
StatePublished - Apr 16 2013

Fingerprint

Neuropilin-2
Oncology
breast neoplasms
Surgery
Haplotypes
Lymphedema
haplotypes
surgery
Genes
Vascular Endothelial Growth Factor C
Forkhead Transcription Factors
Lymphocytes
Vascular Cell Adhesion Molecule-1
Protein-Tyrosine Kinases
genotyping
genes
vascular endothelial growth factor C
Spectroscopy
protein-tyrosine kinases
bioelectrical impedance

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer Surgery. / Miaskowski, Christine; Dodd, Marylin; Paul, Steven M.; West, Claudia; Hamolsky, Deborah; Abrams, Gary; Cooper, Bruce A.; Elboim, Charles; Neuhaus, John; Schmidt, Brian L.; Smoot, Betty; Aouizerat, Bradley E.

In: PLoS One, Vol. 8, No. 4, e60164, 16.04.2013.

Research output: Contribution to journalArticle

Miaskowski, C, Dodd, M, Paul, SM, West, C, Hamolsky, D, Abrams, G, Cooper, BA, Elboim, C, Neuhaus, J, Schmidt, BL, Smoot, B & Aouizerat, BE 2013, 'Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer Surgery', PLoS One, vol. 8, no. 4, e60164. https://doi.org/10.1371/journal.pone.0060164
Miaskowski, Christine ; Dodd, Marylin ; Paul, Steven M. ; West, Claudia ; Hamolsky, Deborah ; Abrams, Gary ; Cooper, Bruce A. ; Elboim, Charles ; Neuhaus, John ; Schmidt, Brian L. ; Smoot, Betty ; Aouizerat, Bradley E. / Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer Surgery. In: PLoS One. 2013 ; Vol. 8, No. 4.
@article{47fa7d49b0024b8aa2965613e684c2ec,
title = "Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer Surgery",
abstract = "The purposes of this study were to evaluate for differences in phenotypic and genotypic characteristics in women who did and did not develop lymphedema (LE) following breast cancer treatment. Breast cancer patients completed a number of self-report questionnaires. LE was evaluated using bioimpedance spectroscopy. Genotyping was done using a custom genotyping array. No differences were found between patients with (n = 155) and without LE (n = 387) for the majority of the demographic and clinical characteristics. Patients with LE had a significantly higher body mass index, more advanced disease and a higher number of lymph nodes removed. Genetic associations were identified for four genes (i.e., lymphocyte cytosolic protein 2 (rs315721), neuropilin-2 (rs849530), protein tyrosine kinase (rs158689), vascular cell adhesion molecule 1 (rs3176861)) and three haplotypes (i.e., Forkhead box protein C2 (haplotype A03), neuropilin-2 (haplotype F03), vascular endothelial growth factor-C (haplotype B03)) involved in lymphangiogensis and angiogenesis. These genetic associations suggest a role for a number of lymphatic and angiogenic genes in the development of LE following breast cancer treatment.",
author = "Christine Miaskowski and Marylin Dodd and Paul, {Steven M.} and Claudia West and Deborah Hamolsky and Gary Abrams and Cooper, {Bruce A.} and Charles Elboim and John Neuhaus and Schmidt, {Brian L.} and Betty Smoot and Aouizerat, {Bradley E.}",
year = "2013",
month = "4",
day = "16",
doi = "10.1371/journal.pone.0060164",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer Surgery

AU - Miaskowski, Christine

AU - Dodd, Marylin

AU - Paul, Steven M.

AU - West, Claudia

AU - Hamolsky, Deborah

AU - Abrams, Gary

AU - Cooper, Bruce A.

AU - Elboim, Charles

AU - Neuhaus, John

AU - Schmidt, Brian L.

AU - Smoot, Betty

AU - Aouizerat, Bradley E.

PY - 2013/4/16

Y1 - 2013/4/16

N2 - The purposes of this study were to evaluate for differences in phenotypic and genotypic characteristics in women who did and did not develop lymphedema (LE) following breast cancer treatment. Breast cancer patients completed a number of self-report questionnaires. LE was evaluated using bioimpedance spectroscopy. Genotyping was done using a custom genotyping array. No differences were found between patients with (n = 155) and without LE (n = 387) for the majority of the demographic and clinical characteristics. Patients with LE had a significantly higher body mass index, more advanced disease and a higher number of lymph nodes removed. Genetic associations were identified for four genes (i.e., lymphocyte cytosolic protein 2 (rs315721), neuropilin-2 (rs849530), protein tyrosine kinase (rs158689), vascular cell adhesion molecule 1 (rs3176861)) and three haplotypes (i.e., Forkhead box protein C2 (haplotype A03), neuropilin-2 (haplotype F03), vascular endothelial growth factor-C (haplotype B03)) involved in lymphangiogensis and angiogenesis. These genetic associations suggest a role for a number of lymphatic and angiogenic genes in the development of LE following breast cancer treatment.

AB - The purposes of this study were to evaluate for differences in phenotypic and genotypic characteristics in women who did and did not develop lymphedema (LE) following breast cancer treatment. Breast cancer patients completed a number of self-report questionnaires. LE was evaluated using bioimpedance spectroscopy. Genotyping was done using a custom genotyping array. No differences were found between patients with (n = 155) and without LE (n = 387) for the majority of the demographic and clinical characteristics. Patients with LE had a significantly higher body mass index, more advanced disease and a higher number of lymph nodes removed. Genetic associations were identified for four genes (i.e., lymphocyte cytosolic protein 2 (rs315721), neuropilin-2 (rs849530), protein tyrosine kinase (rs158689), vascular cell adhesion molecule 1 (rs3176861)) and three haplotypes (i.e., Forkhead box protein C2 (haplotype A03), neuropilin-2 (haplotype F03), vascular endothelial growth factor-C (haplotype B03)) involved in lymphangiogensis and angiogenesis. These genetic associations suggest a role for a number of lymphatic and angiogenic genes in the development of LE following breast cancer treatment.

UR - http://www.scopus.com/inward/record.url?scp=84876180106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876180106&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0060164

DO - 10.1371/journal.pone.0060164

M3 - Article

C2 - 23613720

AN - SCOPUS:84876180106

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e60164

ER -